ProCE Banner Activity

Endocrinologist Audio From Hot Topics in NASH: Screening for NASH in Patients With Diabetes

Audio

Listen as expert endocrinologist faculty explore NASH screening and interplay among NAFLD, metabolic syndrome, CV risk, diabetes risk.

Released: December 05, 2019

Expiration: December 03, 2020

No longer available for credit.

Share

Faculty

Kenneth Cusi

Kenneth Cusi, MD, FACP, FACE

Chief, Division of Endocrinology, Diabetes and Metabolism
The University of Florida
Gainesville, Florida

Provided by

Provided by the American Gastroenterology Association.

ProCE Banner

Supporters

Supported by educational grants from

Allergan

Gilead

Intercept Pharmaceuticals

Partners

Endocrine Society

ProCE Banner

Faculty Disclosure

Primary Author

Kenneth Cusi, MD, FACP, FACE

Chief, Division of Endocrinology, Diabetes and Metabolism
The University of Florida
Gainesville, Florida

Kenneth Cusi, MD, FACP, FACE, has disclosed that he has received consulting fees from Allergan, AstraZeneca, Bristol-Myers Squibb, Cirius, Coherus, Deuterex, Janssen, Genentech, Gilead Sciences, Merck, Novo Nordisk, Pfizer, and Poxel and funds for research support paid to the University of Florida from Cirius, Echosens, Inventiva, Janssen, Lilly, Novartis, Novo Nordisk, Poxel, and Zydus.